Welcome to the Cancer Genomics and the Impact of Next Generation Sequencing Symposium


Thursday, March 10, 2011; 8:15 a.m. - 4 p.m.


Herberman Conference Center at UPMC Cancer Pavilion
UPMC Shadyside, Second floor
5150 Centre Ave.
Pittsburgh, PA 15232


“Personalized Genomic Medicine: The Future is Now”
Mark S. Boguski, MD, PhD
Associate Professor
Center for Biomedical Informatics
Harvard Medical School
Department of Pathology
Beth Israel Deaconess Medical Center

“Whole Genome Approaches to Identify Pharmacogenomic Markers in Oncology”
M. Eileen Dolan, PhD
Department of Medicine Section of Hematology/Oncology
University of Chicago Knapp Center for BioMedical Discovery

“Mining the Cancer Methylome”
Peter W. Laird, PhD
Associate Professor
Director, USC Epigenome Center
Vice Chair of Research for the Department of Surgery
Program Leader, Epigenetics and Regulation, Norris Comprehensive Cancer Center
Departments of Surgery and of Biochemistry and Molecular Biology
University of Southern California, Keck School of Medicine
Norris Comprehensive Cancer Center, USC Epigenome Center

“Structural Rearrangements in Breast Cancer Genomes”
Adrian V. Lee, PhD
Visiting Professor
Department of Pharmacology and Chemical Biology
Director, Womens Cancer Research Center
University of Pittsburgh Cancer Institute
Magee-Womens Research Institute

“Personalized Genomic Analyses of Human Cancer”
Victor E. Velculescu, MD, PhD
Associate Professor of Oncology
Director of Cancer Genetics
Ludwig Center at Johns Hopkins
Codirector of Cancer Biology
Johns Hopkins Kimmel Cancer Center at Jefferson

“Adventures in the Cancer Genome”
Richard K. Wilson, PhD
Director, The Genome Center
Washington University in St. Louis


Registration is now closed for the symposium. Everyone is still welcome to attend and register the morning of the event. However, breakfast and lunch will not be provided for those who have not already registered prior to March 4, 2011.

More Information:

For more information, please call 412-623-3205.

Sponsored by:

University of Pittsburgh Cancer Institute and UPMC Cancer Centers